Publikationen (63) Publikationen, an denen Forscher/innen teilgenommen haben

2024

  1. Impact effects of COVID-19 pandemic on chronic disease patients: A longitudinal prospective study

    Journal of Clinical Nursing, Vol. 33, Núm. 6, pp. 2226-2236

2023

  1. Amyotrophic Lateral Sclerosis and Serum Lipid Level Association: A Systematic Review and Meta-Analytic Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  2. Analysis of University Student Motivation in Cross-Border Contexts

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 11

  3. Current Treatments and New, Tentative Therapies for Parkinson’s Disease

    Pharmaceutics, Vol. 15, Núm. 3

  4. Metabolic Disturbance of High-Saturated Fatty Acid Diet in Cognitive Preservation

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  5. Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease

    Neurology International, Vol. 15, Núm. 4, pp. 1253-1272

  6. Poor Cognitive Agility Conservation in Obese Aging People

    Biomedicines, Vol. 11, Núm. 1

2022

  1. Prevalence of Depression and Related Factors among Patients with Chronic Disease during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

    Diagnostics, Vol. 12, Núm. 12

  2. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis

    Brain Pathology, Vol. 32, Núm. 3

  3. Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives

    Pharmaceutics, Vol. 14, Núm. 6

2021

  1. Current understanding of the physiopathology, diagnosis and therapeutic approach to alzheimer’s disease

    Biomedicines, Vol. 9, Núm. 12

  2. Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 7, pp. 1004-1018

  3. Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage Motoneuron Excitability

    Frontiers in Molecular Neuroscience, Vol. 14

2020

  1. Nitric oxide controls excitatory/inhibitory balance in the hypoglossal nucleus during early postnatal development

    Brain Structure and Function, Vol. 225, Núm. 9, pp. 2871-2884

2019

  1. Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1

    Nature Communications, Vol. 10, Núm. 1

2018

  1. XXXIX Congress of the Spanish Society of Physiological Sciences (SECF), 18-21 September 2018, Cádiz, Spain

    Journal of physiology and biochemistry

2015

  1. Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo

    Neuropharmacology, Vol. 92, pp. 69-79

  2. Membrane-Derived Phospholipids Control Synaptic Neurotransmission and Plasticity

    PLoS Biology, Vol. 13, Núm. 5

2014

  1. Retrograde response in axotomized motoneurons: Nitric oxide as a key player in triggering reversion toward a dedifferentiated phenotype

    Neuroscience, Vol. 283, pp. 138-165

2012

  1. Endogenous rho-kinase signaling maintains synaptic strength by stabilizing the size of the readily releasable pool of synaptic vesicles

    Journal of Neuroscience, Vol. 32, Núm. 1, pp. 68-84